Epigenome-wide Association Studies and the Interpretation of Disease -Omics

被引:142
|
作者
Birney, Ewan [1 ]
Smith, George Davey [2 ]
Greally, John M. [3 ]
机构
[1] EBI, Wellcome Trust Genome Campus, Cambridge, England
[2] Univ Bristol, Sch Social & Community Med, Oakfield House, Oakfield Grove, England
[3] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA
来源
PLOS GENETICS | 2016年 / 12卷 / 06期
基金
英国医学研究理事会;
关键词
DNA METHYLATION; MENDELIAN RANDOMIZATION; HETEROGENEITY; EPIDEMIOLOGY; EPIGENETICS; INFERENCE;
D O I
10.1371/journal.pgen.1006105
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Epigenome-wide association studies represent one means of applying genome-wide assays to identify molecular events that could be associated with human phenotypes. The epigenome is especially intriguing as a target for study, as epigenetic regulatory processes are, by definition, heritable from parent to daughter cells and are found to have transcriptional regulatory properties. As such, the epigenome is an attractive candidate for mediating long-term responses to cellular stimuli, such as environmental effects modifying disease risk. Such epigenomic studies represent a broader category of disease -omics, which suffer from multiple problems in design and execution that severely limit their interpretability. Here we define many of the problems with current epigenomic studies and propose solutions that can be applied to allow this and other disease -omics studies to achieve their potential for generating valuable insights.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Epigenome-wide association studies of allergic disease and the environment
    Cardenas, Andres
    Fadadu, Raj P.
    Koppelman, Gerard H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 152 (03) : 582 - 590
  • [2] Estimands in epigenome-wide association studies
    Kruppa, Jochen
    Sieg, Miriam
    Richter, Gesa
    Pohrt, Anne
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [3] Estimands in epigenome-wide association studies
    Jochen Kruppa
    Miriam Sieg
    Gesa Richter
    Anne Pohrt
    Clinical Epigenetics, 2021, 13
  • [4] Epigenome-Wide Association Studies (EWAS) in Cancer
    Verma, Mukesh
    CURRENT GENOMICS, 2012, 13 (04) : 308 - 313
  • [5] Epigenome-wide association studies in Alzheimer's disease; achievements and challenges
    van den Hove, Daniel L. A.
    Riemens, Renzo J. M.
    Koulousakis, Philippos
    Pishva, Ehsan
    BRAIN PATHOLOGY, 2020, 30 (05) : 978 - 983
  • [6] Epigenome-wide association studies in asthma: A systematic review
    Edris, Ahmed
    den Dekker, Herman T.
    Melen, Erik
    Lahousse, Lies
    CLINICAL AND EXPERIMENTAL ALLERGY, 2019, 49 (07): : 953 - 968
  • [7] Advances in epigenome-wide association studies for common diseases
    Paul, Dirk S.
    Beck, Stephan
    TRENDS IN MOLECULAR MEDICINE, 2014, 20 (10) : 541 - 543
  • [8] Estimation of a significance threshold for epigenome-wide association studies
    Saffari, Ayden
    Silver, Matt J.
    Zavattari, Patrizia
    Moi, Loredana
    Columbano, Amedeo
    Meaburn, Emma L.
    Dudbridge, Frank
    GENETIC EPIDEMIOLOGY, 2018, 42 (01) : 20 - 33
  • [9] Recommendations for the design and analysis of epigenome-wide association studies
    Michels, Karin B.
    Binder, Alexandra M.
    Dedeurwaerder, Sarah
    Epstein, Charles B.
    Greally, John M.
    Gut, Ivo
    Houseman, E. Andres
    Izzi, Benedetta
    Kelsey, Karl T.
    Meissner, Alexander
    Milosavljevic, Aleksandar
    Siegmund, Kimberly D.
    Bock, Christoph
    Irizarry, Rafael A.
    NATURE METHODS, 2013, 10 (10) : 949 - 955
  • [10] Recommendations for the design and analysis of epigenome-wide association studies
    Karin B Michels
    Alexandra M Binder
    Sarah Dedeurwaerder
    Charles B Epstein
    John M Greally
    Ivo Gut
    E Andres Houseman
    Benedetta Izzi
    Karl T Kelsey
    Alexander Meissner
    Aleksandar Milosavljevic
    Kimberly D Siegmund
    Christoph Bock
    Rafael A Irizarry
    Nature Methods, 2013, 10 : 949 - 955